Studies on Polyoxins,Antifungal Antibiotics

Seven additional components, polyoxins C, D, E, F, G, H and I were isolated from polyoxin complex. They have molecular formulae corresponding to C₁₁H₁₅N₃O₈, C₁₇H₂₃N₅O₁₄, C₁₇H₂₃N₅O₁₃, C₂₃H₃₀N₆O₁₅, C₁₇H₂₅N₅O₁₂, C₂₃H₃₂N₆O₁₃ and C₁₉H₂₄N₄O₁₂, respectively. These polyoxins except inactive polyoxins C and I were highly active against various kinds of phytopathogenic fungi. The close structural similarity among them including polyoxins A and B is also discussed.     

Isolation of Novel Antifungal Antibiotics,Ezomycins A1, A2, B1 and B2

From ezomycin complex produced by a strain of Streptomyces were isolated four components named ezomycins A₁ (C₂₆H₄₀N₈O₁₆S), A₂ (C₁₉H₂₈N₆O₁₃), B₁ (C₂₆H₃₉N₇O₁₇S) and B₂ (C₁₉H₂₇N₅O₁₄) which are new pyrimidine nucleosides. Ezomycins A₁ and B₁ containing l-cystathionine were found to be responsible for specific antimicrobial activity of the complex against Sclerotinia and Botrytis species.     

Multispectroscopic insight,morphological analysis and molecular docking studies of CuII-based chemotherapeutic drug entity with human serum albumin (HSA) and bovine serum albumin (BSA)

The interaction studies of Cu^II nalidixic acid–DACH chemotherapeutic drug entity, [C₃₆H₅₀N₈O₆Cu] with serum albumin proteins, viz., human serum albumin (HSA) and bovine serum albumin (BSA) employing UV–vis, fluorescence, CD, FTIR and molecular docking techniques have been carried out. Complex [C₃₆H₅₀N₈O₆Cu] demonstrated strong binding affinity towards serum albumin proteins via hydrophobic contacts with binding constants, K?=?3.18?×?10⁵ and 7.44?×?10⁴ M^–1 for HSA and BSA, respectively implicating a higher binding affinity for HSA. The thermodynamic parameters ΔG, ΔH and ΔS at different temperatures were also calculated and the interaction of complex [C₃₆H₅₀N₈O₆Cu] with HSA and BSA was found to be enthalpy and entropy favoured, nevertheless, complex [C₃₆H₅₀N₈O₆Cu] demonstrated higher binding affinity towards HSA than BSA evidenced from its higher binding constant values. Time resolved fluorescence spectroscopy (TRFS) was carried out to validate the static quenching mechanism of HSA/BSA fluorescence. The collaborative results of spectroscopic studies indicated that the microenvironment and the conformation of HSA and BSA (α–helix) were significantly perturbed upon interaction with complex [C₃₆H₅₀N₈O₆Cu]. Hirshfeld surfaces analysis and fingerprint plots revealed various intermolecular interactions viz., N–H····O, O–H····O and C–H····O linkages in a 2–dimensional framework that provide crucial information about the supramolecular architectures in the complex. Molecular docking studies were carried out to ascertain the preferential binding mode and affinity of complex [C₃₆H₅₀N₈O₆Cu] at the target site of HSA and BSA. Furthermore, only for Transmission electroscopy microscopy micrographs of HSA and BSA in presence of complex [C₃₆H₅₀N₈O₆Cu] revealed major protein morphological transitions and aggregation which validates efficient delivery of complex by serum proteins to the target site.

Communicated by Ramaswamy H. Sarma     

New tailored substituted benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug entities: effect of substituents on DNA binding profile,antimicrobial and cytotoxic activity

New tailored Cu(II) & Zn(II) metal-based antitumor drug entities were synthesized from substituted benzothiazole o?vanillin Schiff base ligands. The complexes were thoroughly characterized by elemental analysis, spectroscopic studies {IR, ¹H & ¹³C NMR, ESI?MS, EPR} and magnetic susceptibility measurements. The structure activity relationship (SAR) studies of benzothiazole Cu(II) & Zn(II) complexes having molecular formulas [C₃₀H₂₂CuN₅O₇S₂], [C₃₀H₂₀Cl₂CuN₅O₇S₂], [C₃₀H₂₀CuF₂N₅O₇S₂], [C₃₀H₂₂N₄O₄S₂Zn], [C₃₀H₂₀Cl₂N₄O₄S₂Zn], and [C₃₀H₂₀F₂N₅O₇S₂Zn], with CT?DNA were performed by employing absorption, emission titrations, and hydrodynamic measurements. The DNA binding affinity was quantified by K _b and K _sv values which gave higher binding propensity for chloro-substituted Cu(II) [C₃₀H₂₀Cl₂CuN₅O₇S₂] complex, suggestive of groove binding mode with subtle partial intercalation. Molecular properties and drug likeness profile were assessed for the ligands and all the Lipinski’s rules were found to be obeyed. The antimicrobial potential of ligands and their Cu(II) & Zn(II) complexes were screened against some notably important pathogens viz., E. coli, S. aureus, P. aeruginosa, B. subtilis, and C. albicans. The cytotoxicity of the complexes [C₃₀H₂₀Cl₂CuN₅O₇S₂], [C₃₀H₂₀CuF₂N₅O₇S₂], [C₃₀H₂₀Cl₂N₄O₄S₂Zn], and [C₃₀H₂₀F₂N₅O₇S₂Zn] were evaluated against five human cancer cell lines viz., MCF?7 (breast), MIA?PA?CA?2 (pancreatic), HeLa (cervix) and Hep?G2 (Hepatoma) and A498 (Kidney) by SRB assay which revealed that chloro-substituted [C₃₀H₂₀Cl₂CuN₅O₇S₂] complex, exhibited pronounced specific cytotoxicity with GI₅₀ value of 4.8 μg/ml against HeLa cell line. Molecular docking studies were also performed to explore the binding modes and orientation of the complexes in the DNA helix.     

Structure Determination of Fatty Acids from Tunicamycin Complex

The structures of ten fatty acids, which were obtained by the hydrolysis of tunicamycin complex, were determined. GLC-mass, ¹H NMR and IR spectra showed that the major acids were trans-α, β-unsaturated iso acids with the formula C₁₄H₂₈O₂, C₁₆H₂₈O₂, C₁₆H₃₀O₂ and C₁₇H₃₂O₂. The minor acids were α, β-unsaturated normal acids and saturated normal and iso acids.     

Studies on Mitomycins,Carcinostatic Antibiotics

Mitomycin A (C₁₆H₁₉O₆N₃) and mitomycin C (C₁₅H₁₈O₅N₄) are pigments which have the quinoid structure. When treated with aqueous ammonia, mitomycin A is converted to mitomycin C. Acid hydrolysis of mitomycin C gave three degradation products, namely, C₁₄H₁₅O₅N₄, C₁₄H₁₅O₆N₃ and C₁₃H₁₄O₅N₂. Acetylation with acetic anhydride and pyridine and methylation with methyl iodide gave monoacetyl and monomethyl derivatives of mitomycin C respectively, though diacetate of demethyl derivatives were obtained when boiled with acetic anhydride.     

Synthesis,inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease

Two mononuclear copper(II) complexes, [Cu(C₁₅H₁₆NO₂)₂] (1) and [Cu(C₆H₉N₂O₄)₂·3H₂O] (2·3H₂O), were synthesised and structurally characterised by single-crystal X-ray analysis. The copper(II) atom adopts a square-planar environment in complex 1, while the geometry in 2·3H₂O could be described as the distorted square pyramidal. Complexes 1 and 2·3H₂O were evaluated for their inhibitory activities against Helicobacter pylori (H. pylori) urease in vitro. They both were found to have strong inhibitory activities against H. pylori urease comparable to that of acetohydroxamic acid (AHA). A docking simulation was performed to position 2 into the H. pylori urease active site to determine the probable binding conformation.     

Anti-SARS drug screening by molecular docking

Summary. Starting from a collection of 1386 druggable compounds obtained from the 3D pharmacophore search, we performed a similarity search to narrow down the scope of docking studies. The template molecule is KZ7088 (Chou et al., 2003, Biochem Biophys Res Commun 308: 148–151). The MDL MACCS keys were used to fingerprint the molecules. The Tanimoto coefficient is taken as the metric to compare fingerprints. If the similarity threshold was 0.8, a set of 50 unique hits and 103 conformers were retrieved as a result of similarity search. The AutoDock 3.011 was used to carry out molecular docking of 50 ligands to their macromolecular protein receptors. Three compounds, i.e., C₂₈H₃₄O₄N₇Cl, C₂₁H₃₆O₅N₆, and C₂₁H₃₆O₅N₆, were found that may be promising candidates for further investigation. The main feature shared by these three potential inhibitors as well as the information of the involved side chains of SARS Cov Mpro may provide useful insights for the development of potent inhibitors against SARS enzyme.     

Synthesis, crystal structure and vibrational spectroscopy of a novel mixed ligands Ni(II) pentaborate: [Ni(C4H10N2)(C2H8N2)2][B5O6(OH)4]2

A novel organic-inorganic hybrid pentaborate [Ni(C₄H₁₀N₂)(C₂H₈N₂)₂][B₅O₆(OH)₄]₂ has been synthesized by hydrothermal reaction and characterized by FT-IR, Raman spectroscopy, elemental analyses and DTA-TGA. Its crystal structure was determined from single crystal X-ray diffraction. The structure consists of isolated polyborate anion [B₅O₆(OH)₄]⁻ and nickel complex cation of [Ni(C₄H₁₀N₂)(C₂H₈N₂)₂]²⁺, in which the two kinds of ligands come from the decomposition of triethylenetriamine material. The [B₅O₆(OH)₄]⁻ units are connected to one another through hydrogen bonds, forming a three-dimensional framework with large channel along the a and c axes, in which the templating [Ni(C₄H₁₀N₂)(C₂H₈N₂)₂]²⁺ cations are located. The assignments of the record FT-IR absorption frequencies and Raman shifts were given.     

Synthesis,crystal structure and biological evaluation of spectroscopic characterization of Ni(II) and Co(II) complexes with N‐salicyloil‐N′‐maleoil‐hydrazine as anticholinergic and antidiabetic agents

[Ni(C₁₁H₉N₂O₅)₂(H₂O)₂]?3(C₃H₇NO) ( 1 ) and [Co(C₁₁H₉N₂O₅)₂(H₂O)₂]?3(C₃H₇NO) ( 2 ) are synthesized and characterized by elemental analysis, FT‐IR spectra, magnetic susceptibility, and thermal analysis. In addition, the crystal structure of Ni(II) complex is presented. Both complexes show distorted octahedral geometry. In 1 and 2, metal ions are coordinated by two oxygen atoms of salicylic residue and two nitrogen atoms of maleic amide residue from two ligands, and two oxygen atoms from two water molecules. In this paper, both compounds showed excellent inhibitory effects against human carbonic anhydrase (hCA) isoforms I, and II, α‐glycosidase, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE). Compounds 1 and 2 had Ki values of 18.36 ± 4.38 and 26.61 ± 7.54 nM against hCA I and 13.81 ± 3.02 and 29.56 ± 6.52 nM against hCA II, respectively. On the other hand, their Ki values were found to be 487.45 ± 54.18 and 453.81 ± 118.61 nM against AChE and 199.21 ± 50.35 and 409.41 ± 6.86 nM against BChE, respectively.     

Rhodium(I) and palladium(II) complexes with the Schiff base 2,2-bis((4S)-4-benzyl-2-oxazoline)

The Schiff base 2,2^′-bis((4S)-4-benzyl-2-oxazoline) (I) and its coordination complexes with rhodium(I) and palladium(II) (and with 1,5-cyclo-octadiene and allyl ligands) have been characterised by single-crystal X-ray diffraction, mass spectrometry, ¹³C and ¹H NMR spectroscopy: [Rh(C₂₀H₂₀N₂O₂)(C₈H₁₂)][Rh₂(C₂₀H₂₀N₂O₂)₂](CF₃SO₃)₃ · (CH₃CH₂O) (II) and [Pd(C₂₀H₂₀N₂O₂)(C₃H₅)]CF₃SO₃ (III). We discuss the reasons for the formation of two complex cations for Rh(I), [Rh(C₂₀H₂₀N₂O₂)(C₈H₁₂)]⁺ (IIa) and [Rh₂(C₂₀H₂₀N₂O₂)₂]²⁺ (IIb), and only one for Pd(II).     

Isolation and Characterization of PDE-I and II,the Inhibitors of Cyclic Adenosine-3′,5′-monophosphate Phosphodiesterase

In the screening for inhibitors of cyclic adenosine-3′,5′-monophosphate phosphodiesterase, two compounds, PDE-I (C₁₃H₁₃N₃O₅) and PDE-II (C₁₄H₁₄N₂O₅), were isolated from culture filtrates of a Streptomyces. Concentrations for 50% inhibitions of PDE-I and PDE-II against the high Km enzyme were 15 µm and 13 µm, and those against the low Km enzyme were 65 µm and 130 µm, respectively. Production, isolation and characterization of these compounds are described.     

Study of the Mechanism of Action of p-Chloromercuribenzoate on Endonuclease from the Bacterium Serratia marcescens

The mechanism of action of p-chloromercuribenzoate (PCMB) on Serratia marcescens nuclease was investigated. The analysis showed that PCMB forms complexes with DNA. Binding of C₇H₅O₂Hg⁺ to DNA changes the secondary structure of the DNA. These changes alter the enzymatic activity of S. marcescens nuclease, which was previously found to be sensitive to the secondary structure of the substrates. The nuclease activity was either suppressed or stimulated in the presence of PCMB depending on the C₇H₅O₂Hg⁺ to nucleotide equivalent ratio. Binding of C₇H₅O₂Hg⁺ to DNA did not form an abortive enzyme–substrate complex. Binding of Mg²⁺ to the C₇H₅O₂Hg–DNA complex caused appropriate changes in secondary structure of the substrate. Since Mg²⁺ and C₇H₅O₂Hg⁺, though differing in the type of metal cation, are similar in their mechanisms of influence on enzymatic activity of S. marcescens nuclease, the identity of other metal-containing effectors in their mechanism of action on Serratia marcescens nuclease is assumed.     

Luminophores of the luminous fungus <Emphasis Type="Italic">Neonothopanus nambi</Emphasis>

Isolation of luminophores from the mycelium of a luminous fungus Neonothopanus nambi is reported. In addition to the emission peak with a maximum at 520–530 nm (the wavelength of visible green light) that corresponded to the maximum of light emission by the fungus in vivo, the fluorescence spectra of the raw extracts contained a peak with a maximum in the visible blue-light range. The luminophore that emitted the blue light was an individual compound with a molecular weight of 894 Da. Calculations that took the isotope composition of chemical elements into account pointed at C₅₂H₆₅N₂O₁₁, C₅₁H₆₅N₄O₁₀, C₅₃H₆₁N₆O₇, C₄₇H₆₅N₄O₁₃, and C₄₆H₆₅N₆O₁₂ as the putative chemical formulae of the luminophore. A sample that contained substances of a yellow color was obtained; these substances emitted fluorescence at the wavelengths of green visible light. The luminophores in this sample probably included riboflavin or derivatives thereof (flavin mononucleotide or flavin adenine dinucleotide).     

Acetylene reduction,H2 evolution and 15N2 fixation in the Alnus incana-Frankia symbiosis

Acetylene reduction, ¹⁵N₂ reduction and H₂ evolution were measured in root systems of intact plants of grey alder (Alnus incana (L.) Moench) in symbiosis with Frankia. The ratios of C₂H₂: ¹⁵N₂ were compared with C₂H₂:N₂ ratios calculated from C₂H₂ reduction and H₂ evolution, and with C₂H₂:N₂ ratios calculated from accumulated C₂H₄ production and nitrogen content. It was possible to calculate C₂H₂:N₂ ratios from C₂H₂ reduction and H₂ evolution because this source of Frankia did not show any hydrogenase activity. The ratios obtained using the different methods ranged from 2.72 to 4.42, but these values were not significantly different. It was also shown that enriched ¹⁵N could be detected in the shoot after a 1-h incubation of the root-system. It is concluded that the measurement of H₂ evolution in combination with C₂H₂ reduction represents a nondestructive assay for nitrogen fixation in a Frankia symbiosis which shows no detectable hydrogenase activity.     

Cobalt(II) complexes of the antibiotic sulfadiazine, the X-ray single crystal structure of [Co(C10H9N4O2S)2(CH3OH)2]

Cobalt(II) complexes of sulfadiazine formulated as [Co(C₁₀H₉N₄O₂S)₂(CH₃OH)₂] and [Co(C₁₀H₉N₄S)₂(H₂O)₂] have been synthesized and characterized by elemental analysis, infrared and UV-Vis spectroscopy and magnetic susceptibility measurements. The crystal structures of the complex [Co(C₁₀H₉N₄O₂S)₂(CH₃OH)₂] and of free sulfadiazine are also reported. The cobalt complex and the sulfadiazine ligand both crystallize in the monoclinic space group, P21/c, with sulfadiazine acting as a bidentate ligand. Cobalt is coordinated to two-sulfonamide nitrogen and the pyrimidine nitrogen of the sulfadiazine. Two molecules of methanol complete the octahedral geometry around the cobalt, with interligand hydrogen bonding between methanol and sulfadiazine. Infrared spectroscopy confirmed the presence of water molecule in the coordination sphere of [Co(C₁₀H₉N₄S)₂(H₂O)₂]. The electronic spectra and magnetic moments of both complexes were similar, indicating that both complexes have similar structure.     

Filiation biochimique des acides phénoliques produits parPenicillium brevi-compactum

Résumé LeP. brevi-compactum produit onze substances phénoliques différentes: l'acide mycophénolique, les acides phénoliques C₁₀H₁₀O₅, C₁₀H₁₀O₆, C₁₀H₁₀O₇ et C₈H₆O₆ et les substances phénoliques non identifiées désignées par les chiffres VI, VII, VIII, IX, X et XI. L'acide mycophénolique et les substances X et XI qui en dérivent, sont synthétisés par la moisissure suivant un processus plus complexe que les autres substances phénoliques et sans rapport direct avec lui. Ces dernières dérivent les unes des autres par une série de transformations dont certaines sont réversibles. Il semble que les substances VI et VII soient des intermédiaires entre C₁₀H₁₀O₇ et C₈H₆O₆, tandis que les substances VIII et IX seraient des produits de réduction de C₁₀H₁₀O₅.

---

Summary P. brevi-compactum produces eleven phenolic different substances, mycophenolic acid, phenolic acids C₁₀H₁₀O₅, C₁₀H₁₀O₆, C₁₀H₁₀O₇ and C₈H₆O₆, and the non-identified substances designed by the numbers VI, VII, VIII, IX, X and XI. Mycophenolic acid and its derivates X and XI are synthesized by the mould according to a process more complex than the other phenolic substances and have no direct connection with them. The latter derive the one from the other, in a succession of transformations some of which are reversible. It seems that the substances VI and III are intermediaries between C₁₀H₁₀O₇ and C₈H₆O₆, the substances VIII and IX being produced by reduction of C₁₀H₁₀O₅.

     

Reactions of VCl3, VCl4 and TiX4 (XCl,Br) with benzofuroxan and its 5-methyl-, 5-chloro- and 5-methoxi-derivatives. I.

By means of the reaction between VCl₃ and benzofuroxan the compound VCl₃·2C₆H₄N₂O₂ was obtained, while in reaction with TiX₄ (XCl, Br) the compounds with stoichiometry TiX₄·C₆H₄N₂O₂ (X Cl, Br) were obtained.Furthermore, with some benzofuroxan derivatives (5-methyl, 5-chloro and 5-methoxi) the complexes MCl₄·2YC₆H₃N₂O₂ (MTi, V; YCH₃O, Cl, CH₃), TiCl₄·YC₆H₃N₂O₂ (YCH₃O, CH₃) and TiBr₄·YC₆H₃N₂O₂ (YCH₃O, Cl, CH₃) have been isolated.The compounds were characterized by elementary analysis, cryoscopic molecular weight determination in nitrobenzene, magnetic measurements and IR, Vis and EPR spectroscopy.     

Studies on the Metabolites of Cochliobolus miyabeanus

Ophiobolosin A and ophiobolosin B have been isolated as metabolites of Cochliobolus miyabeanus from the mycelia cultured on the different media. The former is identical with zizanin (C₂₉H₄₄O₅) and the new molecular formula, C₂₅H₃₈O₄ is presented. They have a biological effect to inhibit the germination and the growth of Oryzo sativa seeds and also an antifungal activity against Trichophyton spp. Here is reported the isolation, some physical and chemical properties and biological activities of ophiobolosins.     

Synthesis and preliminary biological evaluation for the anticancer activity of organochalcogen (S/se) tethered chrysin-based organometallic RuII(η6-p-cymene) complexes

Organochalcogen (S/Se) functionalized chrysin derivatives were synthesized and coordinated with Ru^II(η⁶-p-cymene) to efficiently form ruthenium-based chemotherapeutic drug entities [C₃₁H₃₅O₄SRuCl]; [C₃₁H₃₅O₄SeRuCl]; [C₃₃H₃₁O₄SRuCl]; and [C₃₃H₃₁O₄SeRuCl]. The complexes were thoroughly characterized by analytical and various spectroscopic techniques which include elemental analysis, UV–vis, IR, NMR (¹H, ¹³C, and ⁷⁷Se NMR), and HR-MS. The interaction studies of these Ru(II) complexes were carried out with CT DNA/HSA by employing UV–vis, fluorescence and circular dichroic techniques in view to examine their chemotherapeutic potential. The complexes demonstrated predominant binding toward CTDNA via electrostatic interaction while, the extent of binding was quantified by calculating intrinsic binding constant (K_b) and binding constant (K) values which revealed higher binding affinity of selenium-based chrysin complexes as compared to their thio-analogs, following the order [C₃₁H₃₅O₄SeRuCl]?>?[C₃₃H₃₁O₄SeRuCl]?>?[C₃₁H₃₅O₄SRuCl]?>?[C₃₃H₃₁O₄SRuCl]. Moreover, interaction of these complexes with human serum albumin (HSA) was also investigated which suggested spontaneous interactions of complexes with the protein by hydrogen bonding and van der Waals forces. To visualize the preferential binding sites and affinity of complexes with DNA and HSA molecular docking studies were performed. Additionally, in vitro anticancer activity of the complexes were evaluated by SRB assay on selected cancer cell lines viz., HeLa (cervical), MIA-PA-CA-2 (pancreatic), MCF-7 (breast), Hep-G2 (Hepatoma), and SK-OV-3 (ovarian) which exhibited the superior cytotoxicity of complex [C₃₁H₃₅O₄SeRuCl] as compared to other analogs on selective cancer phenotypes.

Communicated by Ramaswamy H. Sarma